UNIVERSAL COVID-19 BIOBANK: A SUBSET OF THE PENN MEDICINE BIOBANK
The Universal COVID-19 Biobank – a component of the Penn Medicine Biobank – is collecting and storing biological specimens as well as information about people who may or may not have been exposed to the SARS-CoV-2 virus as well as those who have developed COVID-19 disease. This information will be used to help learn more about the risk of developing COVID-19 after exposure, to better understand why different people have different reactions to the virus, why some people get very sick from the virus while others don’t, and to better understand the how other diseases and conditions influence the severity of COVID-19.
Study Description The overall purpose of the biobank is to collect and store biological specimens, such as blood, urine, respiratory specimens, other bodily fluids, and tissue where available, as well as health information. Storing these samples and this information allows researchers to use them for research studies, including but not limited to COVID-19.
For more information on Clinical Trials at Penn medicine, click here.